Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block for Preoperative Pain in Elderly Hip Fractures
NCT04996979Unknown
- Sponsor
- Singapore General Hospital
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in hip fracture, sponsored by Singapore General Hospital. Primary endpoint: Numerical Rating Scale at 15 degrees leg lift at 30 months. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT04996979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996979.